Levosimendan Improves Hemodynamics and Exercise Tolerance in Patients With Pulmonary Hypertension and HFpEF
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JACC: Heart Failure
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP Trial
JACC Heart Fail 2021 Apr 03;[EPub Ahead of Print], D Burkhoff, BA Borlaug, SJ Shah, R Zolty, RJ Tedford, T Thenappan, RT Zamanian, JA Mazurek, JD Rich, MA Simon, ES Chung, F Raza, DT Majure, GD Lewis, IR Preston, S RichFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.